First progesterone-only contraceptive pills to be available to purchase from pharmacies

Following a safety review and public consultation, the MHRA has agreed to reclassify Hana and Lovima film-coated tablets (both contain 75 microgram desogestrel) from prescription only (POM) to Pharmacy (P) for the prevention of pregnancy in women of childbearing age.

SPS commentary:

The public assessment reports contain further information on how the reclassification proposals were assessed, including potential risks and drug interactions, and details of risk management plans and pharmacy support materials.

Source:

Medicines and Healthcare products Regulatory Agency

Resource links:

Hana public assessment report

Lovima public assessment report